3BRONTE V,MOCELLIN S.Suppressive influences in the immune response to cancer[J].J Immunother,2009,32(1):1-11.
4YANG L,PANG Y,MOSES H-L.TGF-b and immune cells:an important regulatory axis in the tumor microenvironment and progression[J].Trends Immunol,2010,31(6):220-227.
5NOMURA T,SAKAGUCHI S.Naturally arising CD25+CD4+ regulatory T cells in tumor immunity[J].Curr Top Microbiol Immunol,2005,293:287-302.
6CHALMIN F,LADOIRE S,MIGNOT G,et al.Membrane-associated Hsp72 from tumor-derived exosomes mediates STAT3-dependent immunosup-pressive function of mouse and human myeloid-derived suppressor cells[J].J Clin Invest,2010,120(2):457-471.
7LIU Z,KIM J H,FALO L D,Jr,et al.Tumor regulatory T cells potently abrogate antitumor immunity[J].J Immunol,2009,182(10):6160-6167.
8WYSOCKI P J,KAZIMIERCZAK U,SUCHORSKA W,et al.Gene-modified tumor vaccine secreting a designer cytokine Hyper-Interleukin-6 is an effective therapy in mice bearing orthotopic renal cell cancer[J].Cancer Gene Ther,2010,17(7):465-475.
9ANTONIA S J,SEIGNE J,DIAZ J,et al.Phase I trial of a B7-1 (CD80) gene modified autologous tumor cell vaccine in combination with systemic interleukin-2 in patients with metastatic renal cell carcinoma[J].J Urol,2002,167(5):1995-2000.
10NEMUNAITIS J.GVAX (GMCSF gene modified tumor vaccine) in advanced stage non small cell lung cancer[J].J Control Release,2003,91(1-2):225-231.
